68 research outputs found
Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity
Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality. Microvascular function has been linked to several risk factors for cardiovascular disease and may be affected in RA. It is, however, presently unknown at what point in the disease course the abnormalities in microvascular function occur. We determined whether microvascular function is already disturbed in early disease-modifying antirheumatic drugs (DMARD)-naive RA patients with low systemic inflammation. Fifteen consecutive RA patients with a median symptom duration of 5Ā months, a C-reactive protein level of ā¤20Ā mg/l and without a history of cardiovascular disease, and age 15 and sex-matched healthy controls were recruited. Endothelium-dependent and endothelium-independent vasodilatation in skin was evaluated with laser Doppler fluxmetry after iontophoresis of acetylcholine and sodium nitroprusside, respectively. Videomicroscopy was used to measure recruitment of skin capillaries after arterial occlusion. CRP and ESR levels were mildly, but significantly elevated in patients compared to controls. No differences in both endothelium-dependent vasodilatation and capillary recruitment were observed between groups [709% (95% CI, 457ā961%) vs 797% (95% CI, 556ā1,037%), PĀ =Ā 0.59 and 37% (95% CI, 26ā47%) vs 41% (95% CI, 31ā50%), Pā=ā0.59, respectively]. Skin microvascular function is preserved in early, DMARD-naive RA patients with moderately active RA but low systemic inflammatory activity. Both the extent of the systemic inflammation and disease duration, therefore, may be important determinants of microvascular dysfunction and subsequent increased risk for cardiovascular disease
Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease
Type 2 diabetes and its major risk factor, obesity, are a growing burden for public health. The mechanisms that connect obesity and its related disorders, such as insulin resistance, type 2 diabetes, and hypertension, are still undefined. Microvascular dysfunction may be a pathophysiologic link between insulin resistance and hypertension in obesity. Many studies have shown that adipose tissue-derived substances (adipokines) interact with (micro)vascular function and influence insulin sensitivity. In the past, research focused on adipokines from perivascular adipose tissue (PVAT). In this review, we focus on the interactions between adipokines, predominantly from PVAT, and microvascular function in relation to the development of insulin resistance, diabetes, and cardiovascular disease
The EMIF-AD PreclinAD study: study design and baseline cohort overview
BACKGROUND: Amyloid pathology is the pathological hallmark in Alzheimerās disease (AD) and can precede clinical
dementia by decades. So far it remains unclear how amyloid pathology leads to cognitive impairment and dementia.
To design AD prevention trials it is key to include cognitively normal subjects at high risk for amyloid pathology and to
find predictors of cognitive decline in these subjects. These goals can be accomplished by targeting twins, with
additional benefits to identify genetic and environmental pathways for amyloid pathology, other AD biomarkers,
and cognitive decline.
METHODS: From December 2014 to October 2017 we enrolled cognitively normal participants aged 60 years and
older from the ongoing Manchester and Newcastle Age and Cognitive Performance Research Cohort and the
Netherlands Twins Register. In Manchester we included single individuals, and in Amsterdam monozygotic twin
pairs. At baseline, participants completed neuropsychological tests and questionnaires, and underwent physical
examination, blood sampling, ultrasound of the carotid arteries, structural and resting state functional brain magnetic
resonance imaging, and dynamic amyloid positron emission tomography (PET) scanning with [18F]flutemetamol. In
addition, the twin cohort underwent lumbar puncture for cerebrospinal fluid collection, buccal cell collection,
magnetoencephalography, optical coherence tomography, and retinal imaging.
RESULTS: We included 285 participants, who were on average 74.8 Ā± 9.7 years old, 64% female. Fifty-eight participants
(22%) had an abnormal amyloid PET scan.
CONCLUSIONS: A rich baseline dataset of cognitively normal elderly individuals has been established to estimate risk
factors and biomarkers for amyloid pathology and future cognitive declin
Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology
With the rapid growth of molecular biology, in vivo imaging of such molecular process (i.e., molecular imaging) has been well developed. The molecular imaging has been focused on justifying advanced treatments and for assessing the treatment effects. Most of molecular imaging has been developed using PET camera and suitable PET radiopharmaceuticals. However, this technique cannot be widely available and we need alternative approach. 123I-labeled compounds have been also suitable for molecular imaging using single-photon computed tomography (SPECT) 123I-labeled meta-iodobenzylguanidine (MIBG) has been used for assessing severity of heart failure and prognosis. In addition, it has a potential role to predict fatal arrhythmia, particularly for those who had and are planned to receive implantable cardioverter-defibrillator treatment. 123I-beta-methyl-iodophenylpentadecanoic acid (BMIPP) plays an important role for identifying ischemia at rest, based on the unique capability to represent persistent metabolic alteration after recovery of ischemia, so called ischemic memory. Since BMIPP abnormalities may represent severe ischemia or jeopardized myocardium, it may permit risk analysis in CAD patients, particularly for those with chronic kidney disease and/or hemodialysis patients. This review will discuss about recent development of these important iodinated compounds
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
Renal sodium handling and haemodynamics are equally affected by hyperinsulinaemia in salt-sensitive and salt-resistant hypertensives
Renal sodium handling and haemodynamics are equally affected by hyperinsulinaemia in salt-sensitive and salt-resistant hypertensives
Renal sodium handling and haemodynamics are equally affected by hyperinsulinaemia in salt-sensitive and salt-resistant hypertensives
Objective It is well-known that insulin induces renal sodium retention. It is not yet known whether insulin's renal effects are involved in the development of salt-sensitive hypertension. We assessed the effects of insulin on renal sodium handling and haemodynamics in 10 salt-sensitive (SS) and 10 salt-resistant (SR) essential hypertensives.Design After a baseline period of 90 min, all subjects underwent a euglycaemic clamp with sequential infusion of a physiological and supraphysiological dose of insulin (50 and 150 mU/kg per h) during 90 min periods each. Time-control studies were performed in the same subjects. Clearances of I-131-hippuran, I-125-iothalamate, sodium and lithium were used to evaluate renal plasma flow (RPF), C-Na/glomerular filtration rate (GFR) and fractional proximal and distal sodium reabsorption.Results Plasma insulin levels and insulin-mediated glucose uptake did not differ between both groups. RPF and GFR showed similar increases during both insulin infusions in both groups. During physiological hyperinsulinaemia, fractional sodium excretion decreased 38% (P = 0.009) in the SS group and 36% (P = 0.002) in the SR group. During supraphysiological hyperinsulinaemia, fractional sodium excretion decreased 49% (P = 0.01) in the SS group and 19% (P = 0.2) in the SR group, not statistically different between both groups. Fractional proximal sodium reabsorption was unaffected and fractional distal sodium reabsorption increased to a similar magnitude in both groups.Conclusion The comparable renal effects of acute exogenous hyperinsulinaemia in SS and SR hypertensives do not support a role for insulin in the development of salt-sensitive hypertension. However, the results do not yet exclude a role for chronic hyperinsulinaemia. (C) 2001 Lippincott Williams & Wilkins.</p
- ā¦